陈旧性心肌梗死患者的血脂异常与治疗现况

Blood lipid pattern and use of lipid-lowering medications in patients with old myocardial infarction

目的 了解陈旧性心肌梗死患者的血脂水平、治疗现况及可能的影响因素。方法 随访我院就诊的陈旧性心肌梗死患者 ,通过问询方式获得出院后病史 ,测定患者的血脂水平并了解其治疗现况。结果 陈旧性心肌梗死患者的血脂异常率为 70 .8% ,且以低密度脂蛋白胆固醇 (LDL C)升高为主 ;随访时的适合治疗率为 70 .8% ,实际治疗率仅 2 0 .6 % ;治疗中患者的血脂控制达标率仅 2 5 .0 %。结论 出院超过 6个月的陈旧性心肌梗死患者的血脂异常率仍较高 ,而调脂治疗现状与应达到的水平还存在较大差距。

Objective To determine the plasma lipid levels, the current therapy status and the possible influencing factors in patients with old infarct(OI) who had received lipid-lowering agents. Methods The patients were followed up after discharge at least for 6 months , and the conditions were acquired recently by questioning the patient and blood lipid examination. Results 70.8% OI needed drug treatment, because of elevated plasma lipid and LDL-C, but actually only 20.6% were positively responsible treatment. 25.0% of patients treated had attained the controlled levels of LDL-C and HDL-C. Conclusion Although lipid-lowering medications may benefit the patients with old myocardial infarction, yet the current treatment status remains far from ideal.